Regenxbio gene therapy refiling plan derailed by FDA hold over spine MRI findings

Newsylist Editorial Desk. (2026, August 24, 2026). Regenxbio gene therapy refiling plan derailed by FDA hold over spine MRI findings: Why it's trending. Newsylist. https://www.newsylist.com/trend/2026-08-24/regenxbio-gene-therapy-refiling-plan-derailed-by-fda-hold-over-spine-mri

@online{newsylist_38057,
  author = {Newsylist Editorial Desk},
  title = {{Regenxbio gene therapy refiling plan derailed by FDA hold over spine MRI findings}},
  year = {2026},
  url = {https://www.newsylist.com/trend/2026-08-24/regenxbio-gene-therapy-refiling-plan-derailed-by-fda-hold-over-spine-mri},
  note = {Tracked across 2 independent newsrooms}
}

> According to Newsylist Editorial Desk ([Regenxbio gene therapy refiling plan derailed by FDA hold over spine MRI findings](https://www.newsylist.com/trend/2026-08-24/regenxbio-gene-therapy-refiling-plan-derailed-by-fda-hold-over-spine-mri)), this event was corroborated across 2 independent sources with a live velocity of 1.